Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Massive Bio

News headline image
Massive Bio Announces Next-Generation Reticulum Nexus™ Product Suite at ASCO 2026
From Massive Bio
Via Business Wire
News headline image
Massive Bio Partners with TOUCH, The Black Breast Cancer Alliance and Navigating Trials to Expand Cancer Patients' Access to Clinical Trials
From Massive Bio
Via Business Wire
News headline image
Massive Bio to Unveil Reticulum Nexus™ as the AI Operating System for Oncology Access at ASCO 2026
From Massive Bio
Via Business Wire
News headline image
Massive Bio and BeeKeeperAI Deploy Federated Confidential Computing to Expand Oncology Trial Access Across Atlanta’s Underserved Communities
From Massive Bio
Via Business Wire
News headline image
Massive Bio and Just Worldwide Announce Strategic Partnership to Connect More Cancer Patients to Clinical Trials
From Massive Bio
Via Business Wire
News headline image
Massive Bio Expands Global Access to Clinical Trials Through AI-Powered Parameterization and Pre-Screening with OpenAI
From Massive Bio
Via Business Wire
News headline image
Massive Bio Publishes Landmark Prospective Study Demonstrating AI-Driven Clinical Trial Matching at Scale in 3,804 Cancer Patients
From Massive Bio
Via Business Wire
News headline image
Massive Bio Launches NexusPulse™, the Real-Time AI Signal Engine for Oncology Markets
From Massive Bio
Via Business Wire
News headline image
Massive Bio Launches TrialRelay™ at SCOPE 2026: An Operating System to End "Referral Black Holes" in Oncology
From Massive Bio
Via Business Wire
News headline image
Massive Bio Collaborates with the American Cancer Society to Accelerate Equitable Access to Cancer Clinical Trials
From Massive Bio
Via Business Wire
News headline image
Massive Bio Announces Reticulum Nexus - an AI-Driven Multi‑Agent Platform Orchestrating the End-to-end Patient Journey
From Massive Bio
Via Business Wire
News headline image
Massive Bio Calls on Congress to Classify ClinicalTrials.gov as Essential Infrastructure Amid Government Shutdown
From Massive Bio
Via Business Wire
News headline image
Massive Bio Launches Oracle Cerner App to Simplify Patient Records and Speed Up Clinical Trial Matching
From Massive Bio
Via Business Wire
News headline image
Massive Bio and Prognos Health Announce Strategic Partnership to Expand Oncology Access
From Massive Bio
Via Business Wire
News headline image
MASSIVE BIO Delivers on CMS Interoperability Vision with Live Patient Connect App and AI Trial Matching Assistant
From Massive Bio
Via Business Wire
News headline image
Massive Bio Recognized in Two Key Categories on CB Insights’ AI Drug Research & Development Market Map
From Massive Bio
Via Business Wire
News headline image
Massive Bio to Showcase AI-Driven Oncology Innovations at ASCO25
From Massive Bio
Via Business Wire
News headline image
Massive Bio Receives CNIL Certification for GDPR Compliance
From Massive Bio
Via Business Wire
News headline image
Massive Bio Stands Committed to Accelerating Cancer Research and Clinical Trial Access Amid NIH Funding Uncertainty
From Massive Bio
Via Business Wire
News headline image
Massive Bio Recognized by White House Cancer Moonshot for First-of-Their-Kind Pre-Screening Hubs and AI-Powered Trial Matching, Launches $15 Million Initiative at JPM 2025
From Massive Bio
Via Business Wire
News headline image
Massive Bio Launches Patient Connect to Personalize Access to Cancer Clinical Trials Globally
From Massive Bio
Via Business Wire
News headline image
Massive Bio and Foundation Medicine Partner to Optimize Clinical Trial Recruitment and Enrollment to Expand Access to Precision Cancer Care
From Massive Bio
Via Business Wire
News headline image
Inocras and Massive Bio Forge Groundbreaking Alliance to Revolutionize Cancer Care with Whole-Genome Insights and Clinical Trial Matching
From Massive Bio
Via Business Wire
News headline image
Massive Bio and Un Ensayo Para Mi Partner to Transform Oncology Clinical Trial Access and Deploy AI Technologies Across LATAM at #ASCO24
From Massive Bio
Via Business Wire
News headline image
Massive Bio and Mika Health Combine AI and Next-Generation Sequencing Biomarker Testing to Empower Cancer Patients On Treatment and Those Searching for and Participating in Clinical Trials in the United States and Europe
From Massive Bio
Via Business Wire
News headline image
Massive Bio to Unveil Drug Utilization Optimizer (DUO) at ASCO Annual Meeting 2024
From Massive Bio
Via Business Wire
News headline image
PCC and Massive Bio Validate Existing AI System in Groundbreaking and Largest Multi-Sponsor Clinical Trial Matching Study
From Massive Bio
Via Business Wire
News headline image
Massive Bio Unveils Groundbreaking Oncology/Hematology AI Platform at ASCO 2024: Revolutionizing Oncology/Hematology with AI Driven Personalized Insights for Clinical Trial Accessibility
From Massive Bio
Via Business Wire
News headline image
Trialbee and Massive Bio Join Forces to Improve Clinical Trial Access and Patient Recruitment for Oncology and Hematology
From Massive Bio
Via Business Wire
News headline image
Further Group Collaborates with Massive Bio, Integrating Health Solutions for the Insurance Industry to Boost Access to Cancer Clinical Trials Globally
From Massive Bio
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.